# ClinicalTrials.gov record NCT04126070

> PeptideScanner retained ClinicalTrials.gov record NCT04126070 at 2026-07-30T16:19:36.912Z. Its registry update date was 2026-05-27, and PeptideScanner's reviewed identity mapping was leuprolide.

- Evidence object: `story:clinicaltrials-gov-nct04126070-leuprolide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-05-27
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct04126070-leuprolide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct04126070-leuprolide-v1.json
- Content SHA-256: `4ea18d628c63ced0dd7d6ef82229d0e1e825d0b8ab0564d298848f563784134c`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT04126070 ([`ctg-observation-nct04126070-2026-05-27-acf7514b1813`](#source-ctg-observation-nct04126070-2026-05-27-acf7514b1813))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT04126070 at 2026-07-30T16:19:36.912Z. Its registry update date was 2026-05-27, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct04126070-2026-05-27-acf7514b1813`](#source-ctg-observation-nct04126070-2026-05-27-acf7514b1813))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT04126070 at 2026-07-30T16:19:36.912Z. Its registry update date was 2026-05-27, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct04126070-2026-05-27-acf7514b1813`](#source-ctg-observation-nct04126070-2026-05-27-acf7514b1813))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct04126070-2026-05-27-acf7514b1813`](#source-ctg-observation-nct04126070-2026-05-27-acf7514b1813))

## Sources

<a id="source-ctg-observation-nct04126070-2026-05-27-acf7514b1813"></a>
- **ClinicalTrials.gov record NCT04126070 · retained source version 2026-05-27:acf7514b1813d851d2aaf9053fd8824b54af7b498f6cc86f937ecd3f5be89b6d** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT04126070) (`ctg-observation-nct04126070-2026-05-27-acf7514b1813`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT04126070." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct04126070-leuprolide-v1.json SHA-256: 4ea18d628c63ced0dd7d6ef82229d0e1e825d0b8ab0564d298848f563784134c.